Private Advisor Group’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,767	Closed	-$348K	–	2326
2024 Q3	$348K	Sell	1,767 -211	-11%	-$43.9K	﹤0.01%	1841
2024 Q2	$409K	Buy	1,978 +273	+16%	+$61.9K	﹤0.01%	1676
2024 Q1	$462K	Buy	1,705 +23	+1%	+$5.49K	﹤0.01%	1570
2023 Q4	$398K	Buy	+1,682	New	+$331K	﹤0.01%	1606
2022 Q3	–	Sell	-1,370	Closed	-$293K	–	1963
2022 Q2	$293K	Buy	1,370 +39	+3%	+$9.53K	﹤0.01%	1658
2022 Q1	$378K	Buy	1,331 +178	+15%	+$54.9K	﹤0.01%	1550
2021 Q4	$434K	Sell	1,153 -15,780	-93%	-$6.13M	﹤0.01%	1518
2021 Q3	$6.99M	Buy	16,933 +7,878	+87%	+$3.27M	0.04%	406
2021 Q2	$3.35M	Buy	9,055 +557	+7%	+$186K	0.03%	554
2021 Q1	$2.46M	Sell	8,498 -1,143	-12%	-$318K	0.02%	625
2020 Q4	$2.41M	Buy	+9,641	New	+$2.3M	0.03%	600
2020 Q3	–	Sell	-256	Closed	-$45K	–	1929
2020 Q2	$45K	Buy	+256	New	+$40.9K	﹤0.01%	2157
2017 Q2	–	Sell	-32,742	Closed	-$769K	–	1397
2017 Q1	$769K	Buy	+32,742	New	+$2.78M	0.02%	624
2014 Q4	–	Sell	-5,567	Closed	-$333K	–	1041
2014 Q3	$333K	Hold	5,567	–	–	0.02%	659
2014 Q2	$298K	Buy	+5,567	New	+$305K	0.03%	656